UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Molecular imaging of prostate cancer

British journal of radiology, 2018-04, Vol.91 (1084), p.20170736-20170736

2018

Volltextzugriff (PDF)

Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience

Surgery research and practice, 2017-01, Vol.2017, p.5924802-5

2017

Volltextzugriff (PDF)

Changes in planned disease management after piflufolastat F 18 PET/CT in men with biochemically recurrent prostate cancer and low PSA levels: A secondary analysis of results from the CONDOR study

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.61-61

2023

Volltextzugriff (PDF)

Voxel-based logistic analysis of PPMI control and Parkinson's disease DaTscans

NeuroImage (Orlando, Fla.), 2017-05, Vol.152, p.299-311

2017

Volltextzugriff (PDF)

Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University

Nuclear medicine communications, 2021-11, Vol.42 (11), p.1277

2021

Volltextzugriff (PDF)

Isolated Multinodular Soft-Tissue Rosai-Dorfman Disease on FDG PET/CT

Clinical nuclear medicine, 2018-02, Vol.43 (2), p.e53-e55

2018

Volltextzugriff (PDF)

Piflufolastat F 18-PET/CT in patients with prostate cancer: An analysis of OSPREY (cohorts A and B) standardized uptake value (SUV) results stratified by PSA and Gleason score

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5024-5024

2022

Volltextzugriff (PDF)

Piflufolastat F 18-PET/CT in prostate cancer patients: An analysis of OSPREY (Cohorts A and B) standardized uptake value (SUV) results stratified by PSA and gleason score

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.35-35

2022

Volltextzugriff (PDF)

Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization

The Journal of nuclear medicine (1978), 2019-08, Vol.60 (8), p.1066-1072

2019

Volltextzugriff (PDF)

A prospective phase 2/3 study of PSMA-targeted 18 F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A sub-analysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e17003-e17003

2021

Volltextzugriff (PDF)

A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.32-32

2021

Volltextzugriff (PDF)

Quantitative Imaging Biomarkers for 90 Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization

Journal of Nuclear Medicine, 2019-08, Vol.60 (8), p.1066-1072

2019

Volltextzugriff (PDF)

Single-photon Emission Computed Tomography-Computed Tomography Using 99m Tc-labeled Leukocytes for Evaluating Infection Associated with a Cranial Implant in a Rhesus Macaque ( Macaca mulatta )

Comparative medicine, 2019-05, Vol.69 (3), p.249-256

2019

Volltextzugriff (PDF)

A prospective phase II/III multicenter study of PSMA-targeted 18F-DCFPyL PET/CT imaging in patients with prostate cancer (OSPREY): A sub-analysis of regional and distant metastases detection rates at initial staging by 18F-DCFPyL PET/CT

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.9-9

2020

Volltextzugriff (PDF)

PSMA-targeted imaging with 18 F-DCFPyL-PET/CT in patients (pts) withbiochemically recurrent prostate cancer (PCa): A phase 3 study (CONDOR)—A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5023-5023

2021

Volltextzugriff (PDF)

PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts) with biochemically recurrent prostate cancer (PCa): A phase III study (CONDOR)—A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.33-33

2021

Volltextzugriff (PDF)

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study

Clinical cancer research, 2021-02, Vol.27 (13), p.3674-3682

2021

Volltextzugriff (PDF)

Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis

Clinical nuclear medicine, 2018-04, Vol.43 (4), p.284-286

2018

Volltextzugriff (PDF)

A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18 F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS5093-TPS5093

2019

Volltextzugriff (PDF)

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Clinical cancer research, 2021-07, Vol.27 (13), p.3674-3682

2021

Volltextzugriff (PDF)

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)

The Journal of urology, 2021-07, Vol.206 (1), p.52

2021

Volltextzugriff (PDF)

Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY

The Journal of nuclear medicine (1978), 2019-05, Vol.60

2019

Volltextzugriff (PDF)

Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): Results from a phase III, prospective, multicenter study (CONDOR)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5501-5501

2020

Volltextzugriff (PDF)

Single-photon Emission Computed Tomography-Computed Tomography Using 99mTc-labeled Leukocytes for Evaluating Infection Associated with a Cranial Implant in a Rhesus Macaque (Macaca mulatta)

Comparative medicine, 2019-05, Vol.69 (3), p.249-256

2019

Volltextzugriff (PDF)

Diagnostic performance of 18 F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of 18 F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5012-5012

2019

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(49)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Humans
(17)
Biological And Medical Sciences
(10)
Male
(10)
Medical Sciences
(9)
Middle Aged
(9)
Radiology, Nuclear Medicine & Medical Imaging
(9)
Female
(8)
Aged
(7)
Neurosciences & Neurology
(6)
Adult
(5)
Neurosciences
(5)
Aged, 80 And Over
(4)
Clinical Neurology
(4)
Computed Tomography
(4)
Biopsy
(3)
Diseases Of Striated Muscles. Neuromuscular Diseases
(3)
Neurology
(3)
Oncology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Molecular imaging of prostate cancer

Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience

Changes in planned disease management after piflufolastat F 18 PET/CT in men with biochemically recurrent prostate cancer and low PSA levels: A secondary analysis of results from the CONDOR study

Voxel-based logistic analysis of PPMI control and Parkinson's disease DaTscans

Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University

Isolated Multinodular Soft-Tissue Rosai-Dorfman Disease on FDG PET/CT

Piflufolastat F 18-PET/CT in patients with prostate cancer: An analysis of OSPREY (cohorts A and B) standardized uptake value (SUV) results stratified by PSA and Gleason score

Piflufolastat F 18-PET/CT in prostate cancer patients: An analysis of OSPREY (Cohorts A and B) standardized uptake value (SUV) results stratified by PSA and gleason score

Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization

A prospective phase 2/3 study of PSMA-targeted 18 F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A sub-analysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging

A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging

Quantitative Imaging Biomarkers for 90 Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization

Single-photon Emission Computed Tomography-Computed Tomography Using 99m Tc-labeled Leukocytes for Evaluating Infection Associated with a Cranial Implant in a Rhesus Macaque ( Macaca mulatta )

A prospective phase II/III multicenter study of PSMA-targeted 18F-DCFPyL PET/CT imaging in patients with prostate cancer (OSPREY): A sub-analysis of regional and distant metastases detection rates at initial staging by 18F-DCFPyL PET/CT

PSMA-targeted imaging with 18 F-DCFPyL-PET/CT in patients (pts) withbiochemically recurrent prostate cancer (PCa): A phase 3 study (CONDOR)—A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth

PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts) with biochemically recurrent prostate cancer (PCa): A phase III study (CONDOR)—A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study

Superior Pituitary Border Analysis in Immunotherapy-Induced Hypophysitis

A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18 F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR)

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)

Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY

Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): Results from a phase III, prospective, multicenter study (CONDOR)

Single-photon Emission Computed Tomography-Computed Tomography Using 99mTc-labeled Leukocytes for Evaluating Infection Associated with a Cranial Implant in a Rhesus Macaque (Macaca mulatta)

Diagnostic performance of 18 F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of 18 F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC)

Suchergebnisse filtern